WO2001044445A2 - Lyases humaines et proteines associees - Google Patents

Lyases humaines et proteines associees Download PDF

Info

Publication number
WO2001044445A2
WO2001044445A2 PCT/US2000/033815 US0033815W WO0144445A2 WO 2001044445 A2 WO2001044445 A2 WO 2001044445A2 US 0033815 W US0033815 W US 0033815W WO 0144445 A2 WO0144445 A2 WO 0144445A2
Authority
WO
WIPO (PCT)
Prior art keywords
hlyap
polynucleotide
polypeptide
sequence
sequences
Prior art date
Application number
PCT/US2000/033815
Other languages
English (en)
Other versions
WO2001044445A8 (fr
WO2001044445A3 (fr
Inventor
Henry Yue
Olga Bandman
Y. Tom Tang
Jennifer L. Hillman
Dyung Aina M. Lu
Mariah R. Baughn
Original Assignee
Incyte Genomics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Genomics, Inc. filed Critical Incyte Genomics, Inc.
Priority to EP00988059A priority Critical patent/EP1242590A2/fr
Priority to JP2001545523A priority patent/JP2003530084A/ja
Priority to AU24309/01A priority patent/AU2430901A/en
Priority to CA002390689A priority patent/CA2390689A1/fr
Publication of WO2001044445A2 publication Critical patent/WO2001044445A2/fr
Publication of WO2001044445A3 publication Critical patent/WO2001044445A3/fr
Publication of WO2001044445A8 publication Critical patent/WO2001044445A8/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

La présente invention concerne d'une part des lyases humaines et protéines associées (HLYAP), et d'autre part des polynucléotides identifiant et codant ces HLYAP. L'invention concerne également de vecteurs d'expression, des cellules hôtes, des anticorps, des agonistes et des antagonistes. L'invention concerne enfin des procédés se rapportant au diagnostic, au traitement ou à la prévention de troubles liés à l'expression des HLYAP.
PCT/US2000/033815 1999-12-16 2000-12-13 Lyases humaines et proteines associees WO2001044445A2 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP00988059A EP1242590A2 (fr) 1999-12-16 2000-12-13 Lyases humaines et proteines associees
JP2001545523A JP2003530084A (ja) 1999-12-16 2000-12-13 ヒトリアーゼおよび関連タンパク質
AU24309/01A AU2430901A (en) 1999-12-16 2000-12-13 Human lyases and associated proteins
CA002390689A CA2390689A1 (fr) 1999-12-16 2000-12-13 Lyases humaines et proteines associees

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17230799P 1999-12-16 1999-12-16
US60/172,307 1999-12-16

Publications (3)

Publication Number Publication Date
WO2001044445A2 true WO2001044445A2 (fr) 2001-06-21
WO2001044445A3 WO2001044445A3 (fr) 2001-12-13
WO2001044445A8 WO2001044445A8 (fr) 2002-06-20

Family

ID=22627151

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/033815 WO2001044445A2 (fr) 1999-12-16 2000-12-13 Lyases humaines et proteines associees

Country Status (5)

Country Link
EP (1) EP1242590A2 (fr)
JP (1) JP2003530084A (fr)
AU (1) AU2430901A (fr)
CA (1) CA2390689A1 (fr)
WO (1) WO2001044445A2 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004013320A1 (fr) * 2002-07-30 2004-02-12 Bayer Healthcare Ag Regulation de la methyltransferase humaine
US7078419B2 (en) 2003-03-10 2006-07-18 Boehringer Ingelheim Pharmaceuticals, Inc. Cytokine inhibitors

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5962302A (en) * 1998-02-20 1999-10-05 Incyte Pharmaceuticals, Inc. Human N-acetylneuraminate lyase

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5962302A (en) * 1998-02-20 1999-10-05 Incyte Pharmaceuticals, Inc. Human N-acetylneuraminate lyase

Non-Patent Citations (9)

* Cited by examiner, † Cited by third party
Title
BAIROCH A: "Prosite: A Dictionary of Protein Sites and Patterns - User Manual; Release 16.0" [Online] July 1999 (1999-07) , EXPASY , GENEVA XP002174193 Retrieved from the Internet: <URL: www.expasy.ch/txt/prosuser.txt> [retrieved on 2001-09-05] the whole document *
DATABASE EMBL [Online] 26 May 1999 (1999-05-26) retrieved from EBI Database accession no. AL049787 XP002174196 *
DATABASE EMBL [Online] 26 May 1999 (1999-05-26) retrieved from EBI Database accession no. AL049788 XP002174197 *
DATABASE EMBL [Online] 27 May 1999 (1999-05-27) retrieved from EBI Database accession no. AI682225 XP002174195 *
DATABASE SWALL [Online] 1 November 1999 (1999-11-01) retrieved from EBI Database accession no. Q9Y273 XP002174194 *
LINSS JUTTA ET AL: "Cloning and characterization of the gene encoding ATP-dependent phosphoenolpyruvate carboxykinase in Trypanosoma cruzi: Comparison of primary and predicted secondary structure with host GTP-dependent enzyme." GENE (AMSTERDAM), vol. 136, no. 1-2, 1993, pages 69-77, XP001018900 ISSN: 0378-1119 *
MATTE ALLAN ET AL: "Crystal structure of Escherichia coli phosphoenolpyruvate carboxykinase: A new structural family with the P-loop nucleoside triphosphate hydrolase fold." JOURNAL OF MOLECULAR BIOLOGY, vol. 256, no. 1, 1996, pages 126-143, XP002174191 ISSN: 0022-2836 *
MATTE ALLAN ET AL: "Structure and mechanism of phosphoenolpyruvate carboxykinase." JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 272, no. 13, 1997, pages 8105-8108, XP002174238 ISSN: 0021-9258 *
WHITBY FRANK G ET AL: "Crystal structure of human uroporphyrinogen decarboxylase." EMBO (EUROPEAN MOLECULAR BIOLOGY ORGANIZATION) JOURNAL, vol. 17, no. 9, 1 May 1998 (1998-05-01), pages 2463-2471, XP002174192 ISSN: 0261-4189 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004013320A1 (fr) * 2002-07-30 2004-02-12 Bayer Healthcare Ag Regulation de la methyltransferase humaine
US7078419B2 (en) 2003-03-10 2006-07-18 Boehringer Ingelheim Pharmaceuticals, Inc. Cytokine inhibitors

Also Published As

Publication number Publication date
WO2001044445A8 (fr) 2002-06-20
WO2001044445A3 (fr) 2001-12-13
EP1242590A2 (fr) 2002-09-25
AU2430901A (en) 2001-06-25
JP2003530084A (ja) 2003-10-14
CA2390689A1 (fr) 2001-06-21

Similar Documents

Publication Publication Date Title
US20040018505A1 (en) Aminoacyl trna synthetases
EP1349939A2 (fr) Aminoacyl arnt synthetases
WO2001090330A2 (fr) Aminoacyl-arnt synthetases
WO2001020004A2 (fr) Proteines phosphatase et proteines kinase
WO2001016334A2 (fr) Enzymes hydrolytiques humains
EP1266001A2 (fr) Facteurs de transcription
EP1228222A2 (fr) Molecules humaines de la transferase
EP1294868A2 (fr) Adenylyl et guanylyl cyclases
WO2001083524A2 (fr) Proteines du metabolisme de l&#39;arn
WO2002004611A2 (fr) Aminoacyl arnt synthetases
WO2001044445A2 (fr) Lyases humaines et proteines associees
WO2002046413A2 (fr) Molecules pour la detection et le traitement de maladies
EP1124951A2 (fr) Tri de nexines
EP1192250A2 (fr) Proteines du metabolisme de l&#39;arn
EP1265919A2 (fr) Molecules associees a la proteine g
WO2001053469A2 (fr) Phosphatases
US20030087268A1 (en) Human lyases and associated proteins
WO2002000840A2 (fr) Lyases humaines
WO2002004510A2 (fr) Proteines liant le nucleotide guanine
WO2001068696A1 (fr) Proteines de reponse immunitaire humaines
US20030121061A1 (en) Human lyases
WO2002030966A2 (fr) Proteines associees a la maladie d&#39;alzheimer
WO2001005969A2 (fr) Proteines de transfert d&#39;electrons
WO2002059283A2 (fr) Enzymes de modification acides nucleiques
EP1246923A2 (fr) Proteines de modification d&#39;adn

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 2390689

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 10168066

Country of ref document: US

ENP Entry into the national phase in:

Ref country code: JP

Ref document number: 2001 545523

Kind code of ref document: A

Format of ref document f/p: F

AK Designated states

Kind code of ref document: C1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: C1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WR Later publication of a revised version of an international search report
WWE Wipo information: entry into national phase

Ref document number: 2000988059

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2000988059

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 2000988059

Country of ref document: EP